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Abstract. 
 
The mitotic checkpoint blocks cell cycle pro-
gression before anaphase in case of mistakes in the 
alignment of chromosomes on the mitotic spindle. In 
budding yeast, the Mad1, 2, 3, and Bub1, 2, 3 proteins 
mediate this arrest. Vertebrate homologues of Mad1, 2, 
3, and Bub1, 3 bind to unattached kinetochores and 
prevent progression through mitosis by inhibiting 
Cdc20/APC-mediated proteolysis of anaphase inhibi-
tors, like Pds1 and B-type cyclins. We investigated the 
role of Bub2 in budding yeast mitotic checkpoint. The 
following observations indicate that Bub2 and Mad1, 2 
probably activate the checkpoint via different path-
ways: (a) unlike the other Mad and Bub proteins, Bub2 
localizes at the spindle pole body (SPB) throughout the 
cell cycle; (b) the effect of concomitant lack of Mad1 or 
Mad2 and Bub2 is additive, since nocodazole-treated 
 
mad1 bub2
 
 and 
 
mad2 bub2
 
 double mutants rereplicate 
DNA more rapidly and efﬁciently than either single 
mutant; (c) cell cycle progression of 
 
bub2
 
 cells in the 
presence of nocodazole requires the Cdc26 APC sub-
unit, which, conversely, is not required for 
 
mad2
 
 cells in 
the same conditions. Altogether, our data suggest that 
activation of the mitotic checkpoint blocks progression 
through mitosis by independent and partially redun-
dant mechanisms.
Key words: budding yeast • Bub2 • mitotic check-
point • anaphase • anaphase-promoting complex
 
I
 
N
 
 eukaryotic cells, the correct transmission of genetic
information relies on surveillance mechanisms, called
checkpoints, that block or delay cell cycle progression
in response to errors concerning the integrity, replication,
and segregation of the genome (Hartwell and Weinert, 1989).
Checkpoint loss results in genome instability and has been
implicated in the evolution of normal cells into cancer
cells.
Once a cell’s chromosomes have been duplicated, their
proper segregation to the daughter cells in anaphase re-
quires the prior execution of a number of processes: a bi-
polar mitotic spindle must be assembled and the chromo-
somes must attach via their kinetochores to microtubules
that associate with opposite poles of this spindle. Subse-
quently, each pair of sister chromatids is aligned on the
metaphase plate by means of the tension exerted on sister
kinetochores. Chromosome alignment during metaphase
depends not only on pulling forces exerted by microtu-
bules on kinetochores, but also on an opposing force ex-
erted by tethers that hold sister chromatids together. This
is the means by which cells determine which DNA mole-
cules are sisters, and it is therefore essential that anaphase
is not initiated before all pairs of sister chromatids have
aligned on the mitotic spindle. The mitotic checkpoint pre-
vents the onset of anaphase and the entry into the next cell
cycle until alignment of chromosomes on the spindle has
been properly accomplished. In the budding yeast 
 
Saccha-
romyces cerevisiae
 
, several genes implicated in the mitotic
checkpoint have been identified by genetic screens. These
include 
 
BUB1-3
 
 (budding uninhibited by benzimidazole;
Hoyt et al., 1991)
 
1
 
 and 
 
MAD1-3 
 
(mitotic arrest deficient;
Li and Murray, 1991). The products of these genes are re-
quired to delay cell cycle progression in response to de-
fects in spindle assembly and, except for Bub2, in kineto-
chore and centromere structure (Hoyt et al., 1991; Li and
Murray, 1991; Wang and Burke, 1995; Pangilinan and
Spencer, 1996). Strikingly, homologues of Mad1, Mad2,
Bub1, and Bub3 have recently been discovered in fission
yeast (He et al., 1997; Bernard et al., 1998) and in higher
eukaryotes (Chen et al., 1996, 1998; Li and Benezra, 1996;
Taylor and McKeon, 1997; Taylor et al., 1998) and found
to be involved in the mitotic checkpoint also in these
organisms. The vertebrate counterparts appear to be lo-
calized at unattached kinetochores during prophase and
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prometaphase; as soon as kinetochores bind to microtu-
bules, centromeric staining of these proteins rapidly van-
ishes (Chen et al., 1996, 1998; Li and Benezra, 1996; Taylor
and McKeon, 1997; Taylor et al., 1998; Gorbsky et al.,
1998). SpBub1, which is so far the only yeast mitotic
checkpoint protein whose localization has been character-
ized, is also recruited to centromeric regions during the
early stages of mitosis; however, a fraction of SpBub1 re-
mains at kinetochores also during metaphase and ana-
phase (Bernard et al., 1998). Altogether, these observa-
tions account for previous evidence that implicated
kinetochores in transmitting an inhibitory signal in the
presence of monooriented chromosomes (Campbell and
Gorbsky, 1995; Nicklas et al., 1995; Rieder et al., 1995).
Moreover, the fact that a mutation affecting the yeast ki-
netochore protein Ndc10 causes defects in the mitotic
checkpoint (Tavormina and Burke, 1998) further strength-
ens the notion of a critical role of kinetochores in this
checkpoint.
Mad and Bub proteins are also likely to be involved in
detecting endogenous errors during mitosis; in fact, bud-
ding yeast 
 
mad
 
 mutants, as well as fission yeast 
 
bub1
 
 mu-
tants, show an increased frequency of spontaneous chro-
mosome loss (Li and Murray, 1991; Bernard et al., 1998),
and microinjection of anti-Mad2 antibodies into mamma-
lian cells results in a premature anaphase onset (Gorbsky
et al., 1998). Furthermore, overexpression of a dominant
negative version of the murine Bub1 causes precocious
exit from mitosis (Taylor and McKeon, 1997). Bub1 is a
protein kinase that can bind and phosphorylate Bub3
(Roberts et al., 1994), whereas Bub3 is required in human
cells for the correct localization of Bub1 at kinetochores
(Taylor et al., 1998). Mad1 forms a complex with Mad2
(Chen et al., 1998) and becomes phosphorylated when the
mitotic checkpoint is activated; its phosphorylation de-
pends on Mad2, Bub1, and Bub3, but not on Bub2 and
Mad3 (Hardwick et al., 1995). Mps1, a protein kinase re-
quired for spindle pole body duplication and mitotic
checkpoint function (Weiss and Winey, 1996), appears to
phosphorylate Mad1 directly (Hardwick et al., 1996). A
combination of genetics and biochemistry based on Mad1
phosphorylation has partially defined a signal transduction
cascade that is activated in response to spindle damage
and results in cell cycle arrest (Hardwick et al., 1995; Rud-
ner and Murray, 1996; Elledge, 1996). This analysis places
Bub1, Bub3, and Mps1 upstream of Mad1 and Mad2,
while Bub2 and Mad3 might act downstream. Altogether,
the above data suggest that Mad1, 2, and 3 and Bub1 and
Bub3 might form a complex at unattached kinetochores
and work in concert to inhibit cell cycle progression, while
the role of Bub2 has not yet been defined.
Mad and Bub proteins are thought to be signal transduc-
ers of the mitotic checkpoint pathway. Recently, a great
deal of evidence points at the anaphase-promoting com-
plex (APC) as the major target of the mitotic checkpoint.
The APC is required for ubiquitination and subsequent
degradation via the proteasome of two sets of proteins:
anaphase inhibitors, like Pds1 in 
 
S
 
.
 
 cerevisiae
 
 (Cohen-Fix
et al., 1996) and Cut2 in 
 
S
 
.
 
 pombe
 
 (Funabiki et al., 1996,
1997), and several other substrates ubiquitinated at the
end of mitosis, like Ase1 (Juang et al., 1997), Cdc5
(Charles et al., 1998; Shirayama et al., 1998), and B-type
cyclins (Irniger et al., 1995; King et al., 1995; Sudakin et al.,
1995). While degradation of Pds1/Cut2 at the metaphase/
anaphase transition is required for sister chromatid sepa-
ration (Yamamoto et al., 1996; Ciosk et al., 1998), degra-
dation of the budding yeast B-type cyclins Clb1-4 contrib-
utes to the inactivation of the Clb1-4/Cdc28 kinases, which
is necessary for exit from mitosis and the subsequent
round of budding and replication (Surana et al., 1993;
Schwob et al., 1994; Dahmann et al., 1995; Piatti et al.,
1996). The APC substrate specificity towards the two sets
of proteins is conferred by cofactors containing WD-40
motifs, such as Cdc20 and Hct1/Cdh1, which bind to the
APC and activate its ubiquitin ligase activity (Townsley
and Ruderman, 1998). Cdc20 (called Slp1 in fission yeast,
Fizzy in 
 
Drosophila
 
, and p55Cdc in vertebrates) is respon-
sible for ubiquitination of Pds1 and entry into anaphase
(Philp and Glover, 1997; Fang et al., 1998a; Kallio et al.,
1998; Lim et al., 1998; Visintin et al., 1998; Shirayama et al.,
1998), whereas Hct1/Cdh1 (homologous to the 
 
Drosophila
 
Fizzy-related protein and Ste9 in 
 
S
 
.
 
 pombe
 
; Sigrist and
Lehner, 1997; Kitamura et al., 1998; Kominami et al.,
1998) promotes ubiquitination of B-type cyclins, Ase1 and
Cdc5 (Schwab et al., 1997; Visintin et al., 1997; Charles et
al., 1998). 
 
CDC20
 
 is an essential gene; temperature-sensi-
tive 
 
cdc20
 
 mutations cause cells to arrest before anaphase,
due to a failure in degrading Pds1 (Yamamoto et al., 1996;
Shirayama et al., 1998). However, when the 
 
PDS1
 
 gene is
deleted, 
 
cdc20
 
 mutants arrest in telophase with high levels
of Clb2/Cdc28 kinase, suggesting that Cdc20 might also
play a role in promoting ubiquitination of mitotic cyclins
or other APC substrates at the end of mitosis (Lim et al.,
1998; Shirayama et al., 1998). Accordingly, 
 
Drosophila
 
Fizzy is involved in the degradation of cyclins A and B
(Dawson et al., 1995; Sigrist et al., 1995; Lorca et al., 1998).
Unlike 
 
CDC20
 
, 
 
HCT1
 
 is totally dispensable for cell viabil-
ity, despite the inability of 
 
hct1
 
 mutants to trigger degrada-
tion of cyclins B in G1 (Schwab et al., 1997; Visintin et al.,
1997; Zachariae et al., 1998). On the other hand, viability
of 
 
hct1
 
 cells depends on the presence of Sic1, a specific
inhibitor of Clb1-4/Cdc28 kinases (Mendenhall, 1993;
Schwob et al., 1994; Schwab et al., 1997; Visintin et al.,
1997). How are Cdc20/APC and Hct1/APC complexes
regulated during the cell cycle? Cdc20 is an unstable pro-
tein, which accumulates early in mitosis and gets degraded
in G1 and S phases with a process at least partially depen-
dent on the APC (Fang et al., 1998a; Prinz et al., 1998;
Shirayama et al., 1998). Conversely, Hct1 is present at
roughly constant levels throughout the cell cycle (Fang
et al., 1998b; Prinz et al., 1998), but its association with the
APC is negatively regulated by the phosphorylation state
of the protein (Zachariae et al., 1998). Both Cln- and Clb-
dependent CDKs promote Hct1 phosphorylation during S,
G2, and M phases, thereby preventing its binding to the
APC. Dephosphorylation of Hct1 at the end of mitosis is
triggered both by Sic1-dependent inactivation of Clb1-6/
Cdc28 kinases and directly by the activity of the Cdc14
phosphatase, which, by dephosphorylating and activating
Sic1 at the same time, engages a feedback loop (Zachariae
et al., 1998; Visintin et al., 1998). These results strongly
support the notion that inactivation of Clb/Cdc28 kinases
is a key event in exiting the cell cycle, not only because of
its self-sustaining nature, but also because it leads to Hct1 
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dephosphorylation and activation, and, therefore, to the
Hct1/APC-dependent degradation of other substrates.
Mad1, 2, and 3 have been found to interact with Cdc20
in yeast cells (Hwang et al., 1998); furthermore, Mad2 has
been shown to associate to Slp1/p55Cdc (Fang et al.,
1998b; Kallio et al., 1998; Kim et al., 1998; Wassmann and
Benezra, 1998) and the APC (Li et al. 1997; Wassmann
and Benezra, 1998) when the checkpoint is active. Overex-
pression of 
 
CDC20
 
 or mutated versions of the protein that
are no longer able to bind Mad1, 2, and 3 cause an inability
to halt the cell cycle in response to microtubule depoly-
merization (Lim and Surana, 1996; Hwang et al., 1998;
Schott and Hoyt, 1998), suggesting that Mad proteins
block cell cycle progression by inhibiting Cdc20. Due to
the similar subcellular localization of Mad1, 2, 3, Bub1,
and Bub3, current models envision these five proteins to
monitor kinetochore attachment to microtubules and to
prevent, through inhibition of Cdc20, the APC-depen-
dent ubiquitination of Pds1 and cyclins, thereby blocking
the onset of anaphase and exit from mitosis.
Very little is known about the role of Bub2 in the mi-
totic checkpoint and how it interacts with the other Mad
and Bub proteins. Both Bub2 and its fission yeast counter-
part, Cdc16, are required to maintain high levels of histone
H1 kinase activity in response to spindle defects (Hoyt et al.,
1991; Fankhauser et al., 1993). In addition, Cdc16 has been
implicated in coordinating mitosis with septation and cy-
tokinesis (Fankhauser et al., 1993). Some evidence suggests
that Bub2 might play a different role from the other Mad
and Bub proteins in activating the mitotic checkpoint. As
mentioned above, unlike the other Mad and Bub proteins,
Bub2 is not required for the anaphase delay generated
by centromere DNA mutations or impaired kinetochore
function (Wang and Burke, 1995; Pangilinan and Spencer,
1996). Thus, it has been proposed that Bub2 might be part
of a separate checkpoint that responds to abnormal spin-
dle structure rather than to the lack of kinetochore-micro-
tubule attachment (Wang and Burke, 1995).
To gain new insights into the role of Bub2 in the mitotic
checkpoint, we have investigated the subcellular localiza-
tion of Bub2 in budding yeast and its relationships with the
other checkpoint proteins. We find that Bub2 is constitu-
tively localized at spindle pole bodies throughout the cell
cycle and in the presence of microtubule depolymerizing
drugs. Furthermore, we show that 
 
BUB2
 
 belongs to a dif-
ferent epistasis group from 
 
MAD1
 
 and 
 
MAD2
 
, since 
 
bub2
mad2
 
 and 
 
bub2 mad1
 
 double mutants are much more de-
fective in the mitotic checkpoint than either single mutant
or 
 
mad1 mad2
 
 cells. Finally, we find that cell cycle pro-
gression of 
 
bub2
 
 mutant cells in the presence of nocoda-
zole depends on Cdc26, a dispensable APC subunit nei-
ther required in wild-type cells for anaphase and exit from
mitosis during an unperturbed cell cycle at 25
 
8
 
C (Zachar-
iae et al., 1996), nor in 
 
mad2
 
 cells in the presence of micro-
tubule depolymerizing drugs. Together these data suggest
that Bub2 activates the checkpoint via a distinct pathway
from that involving the other Mad and Bub proteins char-
acterized so far.
 
Materials and Methods
 
Strains, Media, and Reagents
 
All yeast strains were derivatives of or were backcrossed at least three
times to W303 (
 
ade2-1
 
,
 
 trp1-1
 
,
 
 leu2-3
 
,
 
112
 
,
 
 his3-11,15
 
,
 
 ura3
 
,
 
 
 
and 
 
ssd1
 
).
Strains used for this work are listed in Table I. Cells were grown in YEP
medium (1% yeast extract, 2% bactopeptone, and 50 mg/liter adenine)
supplemented with 2% glucose (YEPD). 
 
a
 
 factor was used at 2 
 
m
 
g/ml, un-
less otherwise stated, nocodazole at 15 
 
m
 
g/ml, benomyl at 12.5 
 
m
 
g/ml and
hydroxyurea at 150 mM. All the experiments were performed at 25
 
8
 
C,
with the exception of those involving the ts mutants 
 
mps1-1
 
 and 
 
ndc10-1
 
,
which were performed at 37
 
8
 
C.
 
Table I. Yeast Strains Used in This Study
 
Strain Relevant genotype
 
ySP460
 
MATa, ndc10::NDC10myc6::TRP1
 
ySP464
 
MATa, mad2::URA3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP520
 
MATa, cdc26::K.l.URA3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP601
 
MATa, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP710
 
MATa, bub2::BUB2myc9::TRP1
 
ySP862
 
MATa, bub2::URA3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP874
 
MATa, mad1::LEU2, bub2::BUB2myc9::TRP1
 
ySP875
 
MATa, mad2::URA3, bub2::BUB2myc9::TRP1
 
ySP876
 
MATa, mad3, bub2::BUB2myc9::TRP1
 
ySP877
 
MATa, bub1-1, bub2::BUB2myc9::TRP1
 
ySP879
 
MATa, ndc10-1, bub2::BUB2myc9::TRP1
 
ySP880
 
MATa, mps1-1, bub2::BUB2myc9::TRP1
 
ySP906
 
MATa, bub3::LEU2, bub2::BUB2myc9::TRP1
 
ySP921
 
MATa, mad2::URA3, bub2::URA3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP978
 
MATa, cdc26::K.l.URA3, bub2::URA3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP984
 
MATa, mad1::LEU2, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP987
 
MATa, mad2::URA3, mad1::LEU2, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP1016
 
MATa, mad2::TRP1, bub2::HIS3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO, PDS1myc18::LEU2
 
ySP1072
 
MATa, bub2::HIS3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO, PDS1myc18::LEU2
 
ySP1094
 
MATa, mad2::URA3, cdc26::K.l.URA3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP1104
 
MATa, mad1::LEU2, bub2::HIS3, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO
 
ySP1125
 
MATa, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO, PDS1myc18::LEU2
 
ySP1145
 
MATa, mad2::TRP1, leu2::LEU2::tetR-GFP, ura3::URA3::224XtetO, PDS1myc18::LEU2 
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Plasmid Constructions and Genetic Manipulations
 
Standard genetic techniques were used to manipulate yeast strains (Sher-
man, 1991) and standard protocols were used for genetic manipulations
(Maniatis et al., 1992). For tagging 
 
BUB2
 
 at the COOH terminus, a NotI
cassette containing nine tandem repeats of the myc epitope (myc9; Piatti
et al., 1996) was inserted before the termination codon of the HindIII-
EcoRI COOH-terminal fragment of 
 
BUB2
 
 subcloned in Yiplac204. The
resulting plasmid (pSP49) was cut with BclI for integration at the 
 
BUB2
 
locus of W303, thus generating a full-length tagged version of 
 
BUB2
 
flanked by a truncated untagged version of the gene (strain ySP710). For
tagging 
 
NDC10
 
 at the COOH terminus, a NotI cassette containing six
copies of the myc epitope (myc6; Piatti et al., 1996) was inserted before
the termination codon of the NdeI/XbaI COOH-terminal fragment of
 
NDC10
 
 subcloned in pRS304. The resulting plasmid (pSP18) was cut with
BclI for integration at the 
 
NDC10
 
 locus of W303, thus generating a full-
length tagged version of 
 
NDC10
 
 flanked by a truncated untagged version
of the gene (strain ySP460).
 
Western Blot Analysis
 
For Western blot analysis, protein extracts were prepared by TCA precip-
itation (see Fig. 3) as previously described (Piatti et al., 1996) or as de-
scribed in Surana et al., 1993 (see Fig. 6 B). Proteins were transferred to
Protran membranes (Schleicher and Schuell). myc-tagged Bub2 and Pds1
were detected with 9E10 mAb, whereas polyclonal antibodies (Amon et al.,
1992) were used to detect Clb2. Anti-actin antibodies were purchased
from Sigma Chemical Co. Secondary antibodies were purchased from
Amersham and proteins were detected by an enhanced chemilumines-
cence system according to the manufacturer.
 
Other Techniques
 
Flow cytometric DNA quantitation was determined according to Epstein
and Cross (1992) on a Becton Dickinson FACScan
 
®
 
. In situ immunofluo-
rescence was performed according to Nasmyth et al. (1990). Visualization
of Tet operators using GFP and chromosome spreading were performed
as described in Michaelis et al., 1997. Immunostaining of Bub2myc9 and
Ndc10myc6 were detected by incubation with the 9E10 mAb followed by
indirect immunofluorescence using CY3-conjugated goat anti–mouse Ab
(1:500; Amersham); signals were amplified using a CY3-conjugated don-
key anti–goat Ab (1:500; Amersham). Spindle pole bodies were visualized
with polyclonal anti-Spc72 (Knop and Schiebel, 1998) followed by incuba-
tion with FITC-conjugated anti–rabbit Ab (1:50, Jackson ImmunoRe-
search Labs.).
 
Results
 
Deletion of BUB2 or MAD2 Does Not Cause 
Detectable Advancement of Mitosis during a Normal 
Cell Cycle
 
Since the mitotic checkpoint is thought to play an impor-
tant role while chromosomes try to reach a bipolar attach-
ment to the spindle, and inactivation of proteins involved
in the mitotic checkpoint increases the frequency of chro-
mosome loss (Li and Murray, 1991; Bernard et al., 1998),
we asked whether the checkpoint proteins Mad2 and Bub2
had any role in the timing of sister chromatid separation
during a normal cell cycle. For this purpose, we con-
structed wild-type, 
 
bub2
 
D
 
, and 
 
mad2
 
D
 
 strains carrying the
tetR-GFP/tetO constructs which allow to monitor sisters
separation at the centromeric regions of chromosome V
(Michaelis et al., 1997). Cell cultures of the above strains
were synchronized in G1 by 
 
a
 
 factor treatment and re-
leased into fresh medium either lacking or containing the
microtubule depolymerizing drug nocodazole, which ac-
tivates the mitotic checkpoint. As previously reported
(Hoyt et al., 1991; Li and Murray, 1991; Straight et al.,
1996), in the presence of nocodazole both 
 
bub2
 
D
 
 and
 
mad2
 
D
 
 cells lost the cohesion between sister chromatids,
rebudded, and rereplicated, accumulating with DNA con-
tents higher than 2C, whereas wild-type cells arrested in
G2 as dumbbells with duplicated but unseparated chromo-
somes (Fig. 1 B). Interestingly, we reproducibly found that
in these conditions 
 
bub2
 
D
 
 mutants separated sister chro-
matids and started rereplicating later than 
 
mad2
 
D
 
, sug-
gesting that, in the absence of Bub2, entry into anaphase
can be still somewhat delayed by other mechanisms. With-
out nocodazole, all three strains underwent anaphase and
proceeded through the cell cycle with similar kinetics (Fig.
1 A), thus indicating that either Mad2 and Bub2 have no
role in the timing of sister chromatid separation during a
normal cell cycle or bipolar chromosome attachment to
spindle fibers in budding yeast might be a process too fast
and efficient in order to allow detection of subtle differ-
ences in the timing of anaphase entry in the absence of
surveillance mechanisms.
Figure 1. Lack of Mad2 or Bub2 does not advance anaphase dur-
ing an unperturbed cell cycle. Log phase cultures of ySP601
(WT), ySP464 (mad2D), and ySP862 (bub2D) strains were ar-
rested with a factor (time 5 0) and then released into fresh me-
dium either lacking (A) or containing (B) nocodazole. At the in-
dicated time points cell samples were withdrawn for flow
cytometry analysis of the DNA contents and to score budding
and separation of sister chromatids. The latter was determined by
scoring the signals from tetR-GFP in ethanol-fixed cells. Repro-
ducible results were obtained in three independent experiments. 
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Bub2p Is Localized at the Spindle Pole Body
 
Since Mad1, Mad2, Bub1, and Bub3 have been found asso-
ciated to unattached kinetochores during prophase and
prometaphase in higher eukaryotic cells (Chen et al., 1996,
1998; Li and Benezra, 1996; Taylor and McKeon, 1997;
Taylor et al., 1998), while the intracellular localization of
Bub2 had not been established and little was known about
its relationships with other mitotic checkpoint proteins, we
analyzed the subcellular localization of Bub2. We tagged
Bub2 at the COOH terminus with nine copies of the myc
epitope, thus generating the Bub2myc9 variant, which was
fully functional, as judged by the checkpoint proficiency of
 
BUB2myc9
 
 cells in nocodazole (see Fig. 3 A and not
shown). Since Bub2myc9 staining in whole cells was fairly
homogeneous and it was difficult to distinguish specific
staining from the background observed with the same an-
tibody on cells lacking tagged Bub2, we studied the pro-
tein localization by indirect immunofluorescence on chro-
mosome spreads (Klein et al., 1992; Tanaka et al., 1997).
By this technique, squashed nuclei stick to the slide and
nucleoplasmic proteins are washed away, allowing detec-
tion of proteins bound to subnuclear insoluble structures,
such as chromatin and nuclear cytoskeleton. We found
that in all nuclei, Bub2myc9 staining was concentrated in
one or two dots, very reminiscent of spindle pole bodies
 
(SPBs). We, therefore, repeated the experiment by double
staining the spreads with both anti-myc and anti-Spc72 an-
tibodies, the latter of which recognize a constitutive SPB
component (Knop and Schiebel, 1998). As shown in Fig. 2
A, the Bub2myc9 and Spc72 stainings completely over-
lapped, indicating that Bub2 resides at SPBs. As a control,
we performed a double staining of the kinetochore protein
Ndc10 and Spc72. To this purpose, we used a strain where
the only functional copy of 
 
NDC10
 
 was expressing a
protein tagged with six copies of the myc epitope at
the COOH terminus (Ndc10myc6). As it was previously
shown for yeast centromeres (Funabiki et al., 1993; Guacci
et al., 1997; Jin et al., 1998b), we found that Ndc10myc6
formed clusters near the SPBs, both in cycling and in no-
codazole-arrested cells (Fig. 2 B). However, not only
Ndc10 clusters had a different shape compared with that
of SPBs and Bub2, but not all Ndc10myc6 clusters colocal-
ized with Spc72, while Bub2myc9 always did. Although we
cannot fully prove that the Ndc10myc6 clusters corre-
spond to kinetochores, these data strongly suggest that
Bub2 does not localize at kinetochores.
We then investigated further whether Bub2 protein lev-
els and localization varied during the cell cycle and after
nocodazole treatment. To this purpose, the 
 
BUB2myc9
 
strains were released from an 
 
a
 
 factor G1 arrest, and the
Figure 2. Bub2 is localized at SPBs. (A) Cycling ySP710 (Bub2myc9) cells and nocodazole arrested cells (noc) of the same strain, ob-
tained from the experiment in Fig. 3, were processed for chromosome spreading. Chromosome spreads were decorated with anti-myc
antibodies (9E10), followed by detection with CY3-conjugated anti–mouse antibodies, and with anti-Spc72 polyclonal antibodies, fol-
lowed by detection with FITC-conjugated anti–rabbit antibodies. (B) Cycling ySP460 (Ndc10myc6) cells were treated with nocodazole
for three hours. Both cycling and nocodazole arrested cells were processed as in A. 
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Bub2myc9 protein levels and localization were analyzed at
different time points. An aliquot of the synchronized cul-
ture was also incubated for 3 h in nocodazole. Bub2myc9
protein levels remained constant throughout the cell cycle
and when the mitotic checkpoint was activated (Fig. 3 B).
Furthermore, the protein is constitutively localized at
SPBs: G1 cells showed a single dot of Bub2myc9 staining,
whereas two bright dots started appearing at the time of
bud emergence and entry into S phase, which coincides
with the time of SPB duplication (data not shown). About
30–40% of G1 nuclei displayed a fainter staining of Bub2
at SPBs than during the other cell cycle phases, regardless
of growth conditions. About 55% of nuclei from nocoda-
zole arrested cells showed two bright dots of Bub2myc9
staining side by side (Fig. 2 A). This is, in these conditions,
the typical spatial arrangement observed by electron mi-
croscopy for SPBs, which are duplicated but do not mi-
grate apart in the absence of microtubules (Goetsch, L.,
and B. Byers, personal communication). Therefore, the
nuclei showing single SPB signals by immunofluorescence
(
 
z
 
40%) under the same conditions likely had duplicated
SPBs, which could not be resolved by this technique. Fi-
nally, we found that the localization of Bub2myc9 at SPBs
was unaffected in the mitotic checkpoint mutants 
 
mad1
 
D
 
,
 
mad2
 
D
 
, 
 
mad3
 
, bub1-1, bub3D, mps1-1, and ndc10-1 (data
not shown). Therefore, Bub2 is constitutively present at
SPBs during the cell cycle and its localization does not re-
quire any of the analyzed mitotic checkpoint proteins.
Bub2 Checkpoint Function Is Also Required after
SPBs Separation
The finding that Bub2 is localized at SPBs, and SPBs are
mostly unseparated in nocodazole, prompted us to investi-
gate whether Bub2 could be required to delay cell cycle
progression only before SPB separation. For this purpose,
bub2D, mad2D, and wild-type cells were synchronized by
hydroxyurea (HU) treatment, which blocks DNA synthe-
sis but allows duplication and separation of SPBs, thus ar-
resting cells in S phase with short bipolar spindles. Cell
cultures were then released from the HU block into no-
codazole containing medium, in order to disassemble the
previously formed spindles, and cell cycle progression of
the three strains was analyzed. Formation and disassembly
of the spindle in HU and in nocodazole, respectively, was
confirmed by immunostaining of tubulin (data not shown).
As shown in Fig. 4, under these conditions wild-type cells
arrested in G2, with 2C DNA contents and unseparated
sister chromatids, while mad2D and bub2D cells attempted
to undergo anaphase and entered a new cell cycle, as indi-
cated by their ability to separate sister chromatids and re-
replicate DNA. Therefore, both Mad2 and Bub2 check-
point functions are required also after SPBs separation
and bipolar spindle formation.
Bub2 and Mad1/Mad2 Activate the Mitotic Checkpoint 
via Separate Pathways
Since we found Bub2 concentrated at SPBs, whereas
Mad1 and Mad2 are localized, at least in higher eukary-
Figure 3. Bub2 protein levels do not vary during the cell cycle. A
cycling culture of ySP710 strain (Bub2myc9) was arrested with a
factor (time 5 0) and then released from the G1 block. An ali-
quot of the synchronized culture was also incubated for 3 h with
nocodazole. At different time points cell samples were collected
to monitor cell cycle progression by flow cytometry analysis of
the DNA content and to follow the kinetics of budding (A), or to
study Bub2 protein levels by Western analysis using anti-myc
(9E10) antibodies (B). During the course of this experiment lo-
calization of Bub2myc9 in chromosome spreads was also investi-
gated and did not show any qualitative difference with staining
shown in Fig. 2. cyc, cycling cells; NOC, nocodazole.
Figure 4. Bub2 is required for checkpoint activation also after
separation of SPBs. Log phase cultures of ySP601 (WT), ySP464
(mad2D), and ySP862 (bub2D) strains were arrested in early S
phase by HU treatment (time 5 0) and then released into no-
codazole-containing medium. Distribution of DNA contents ob-
tained by flow cytometry analysis at the indicated times and ki-
netics of sister chromatids separation are shown. cyc, cycling
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otes, at unattached kinetochores, we asked whether Bub2
and Mad1, 2 might activate the mitotic checkpoint via dif-
ferent pathways.
To address this question, we first constructed mad1D
bub2D and mad2D bub2D double mutants, and compared
their sensitivity to the microtubule depolymerizing drug
benomyl to that of the single mutants. In fact, hypersensi-
tivity to benomyl of mad and bub mutants correlates with
their mitotic checkpoint defect (Hoyt et al., 1991; Li and
Murray, 1991), and inactivation of two proteins that lead
to checkpoint arrest by different routes should result in a
more severe checkpoint defect, and therefore in an in-
creased benomyl sensitivity, compared with inactivation of
either one. As shown in Fig. 5, mad1D bub2D and mad2D
bub2D cells were much more sensitive to benomyl than
mad1D, mad2D, and bub2D cells, suggesting that BUB2
belongs to an epistasis group different from that of MAD1
and MAD2.
We then verified whether the increased benomyl sensi-
tivity of mad2D bub2D and mad1D bub2D double mutants
correlated with an enhanced checkpoint defect. Cultures
of mad1D, mad2D, bub2D, mad1D bub2D, mad2D bub2D,
mad1D mad2D and wild-type strains were arrested with a
factor and released in either the presence or the absence
of nocodazole. Progression through the cell cycle in the
absence of nocodazole was very similar in all strains (data
not shown); however, in the presence of the drug mad1D
bub2D and mad2D bub2D cells started rereplicating much
faster and more efficiently than the single mutants and the
mad1D mad2D double mutant (Fig. 6 A). Since the timing
and efficiency of rereplication likely reflect the kinetics by
which cyclin B–dependent kinases are inactivated, these
data suggest that mad1D bub2D and mad2D bub2D double
mutants advance inactivation of Clb-kinases with respect
to the other mutants. Conversely, deletion of BUB2 in
mad1D or mad2D cells did not accelerate their timing of
sister chromatids separation (Fig. 6 A), indicating that
Bub2 might play only a minor role in controlling degrada-
tion of the anaphase inhibitor Pds1. We then measured di-
rectly by Western blot analysis the levels of Pds1 and Clb2
during a similar experiment, where mad2D, bub2D, mad2D
bub2D and wild-type strains expressed a myc-tagged Pds1
protein (Shirayama et al., 1998). As shown in Fig. 6 B,
Clb2 was degraded in both mad2D and bub2D cells in no-
codazole, suggesting that rereplication in these mutants is
likely to result from their inability to prevent cyclin pro-
teolysis. In addition, Clb2 disappeared more rapidly in the
mad2D bub2D double mutant than in either single mutant,
thus confirming that acceleration in the kinetics of rerepli-
cation in the double mutant correlates with an advanced
inactivation of Clb/Cdk1 kinases. Although bub2D cells
did also degrade Pds1, they did it very slowly, whereas
Pds1 disappeared very rapidly and with nearly identical ki-
netics in both mad2D and mad2D bub2D cells. Thus, Pds1
degradation and the onset of anaphase appear to be
mainly controlled by a Mad2-dependent pathway that
does not seem to require Bub2. Altogether these data,
while confirming that Mad1 and Mad2 are involved in the
same pathway, indicate that Bub2 and Mad2 prevent
B-type cyclin proteolysis by different routes, since the con-
comitant lack of Mad2 (or Mad1) and Bub2 has an addi-
tive effect on Clb2 degradation, exit from mitosis and en-
try into a new cell cycle. Conversely, Bub2 seems to play
only a minor role, if any, in controlling the onset of
anaphase.
The Cdc26 APC Subunit Is Required for Cell Cycle 
Progression in Nocodazole of bub2D but Not
mad2D Cells
Since mitotic checkpoint arrest involves APC inactivation
(He et al., 1997; Li et al., 1997; Hwang et al., 1998; Kim et al.,
1998; Schott and Hoyt, 1998), it was possible that differ-
ent APC subunits might be alternatively involved in the
Mad2- and the Bub2-dependent checkpoint response. To
address this question, we asked whether various APC sub-
units were required for cell cycle progression of mad2D or
bub2D mutants in the presence of microtubule depoly-
merizing drugs. Unfortunately, most apc mutations are
temperature sensitive and cause a cell cycle arrest in
metaphase already during an otherwise unperturbed cell
cycle (Irniger et al., 1995; Zachariae et al., 1996; Hwang
and Murray, 1997). Furthermore, bub2D mutants show a
poor checkpoint defect at 378C (data not shown). How-
ever, we were able to test whether CDC26, which is totally
dispensable in a normal cell cycle at 258C (Zachariae et al.,
1996), might become indispensable for cell cycle progres-
sion of either mad2D or bub2D cells in the presence of no-
codazole. The role of Cdc26 in the mitotic checkpoint was
also of particular interest as we found that cdc26D mutants
are hypersensitive to benomyl at the permissive tempera-
ture (Amato, S., and S. Piatti, unpublished results). Cell
cycle progression of mad2D  cdc26D and bub2D  cdc26D
double mutants was compared with that of each single mu-
tant after release from a factor in the presence of nocoda-
zole at 258C. As shown in Fig. 7, bub2D cdc26D cells failed
to proceed in the cell cycle and arrested mostly in G2 with
Figure 5. BUB2 belongs to a different epistasis group from
MAD1 and MAD2. Serial dilutions of YEPD-saturated cultures
of strains ySP601 (wt), ySP464 (mad2D), ySP862 (bub2D),
ySP984 (mad1D), ySP921 (mad2D bub2D), and ySP1104 (mad1D
bub2D) were spotted on YEPD plates either containing or lack-
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duplicated and unseparated chromosomes. Conversely,
deletion of CDC26 did neither affect the time of anaphase
onset nor cell cycle progression of mad2D cells. These re-
sults indicate that under these conditions Cdc26 becomes
Figure 6. Bub2 prevents exit from mi-
tosis and rereplication in nocodazole
via a distinct pathway from Mad1/2.
(A) Logarithmically growing cultures
of strains ySP601 (WT), ySP464
(mad2D), ySP862 (bub2D), ySP984
(mad1D), ySP1104 (mad1D  bub2D),
ySP921 (mad2D  bub2D), and ySP984
(mad1D mad2D) were synchronized in
G1 with a factor (time 5 0) and then
released into medium containing or
lacking (not shown) nocodazole. At
the indicated time points DNA con-
tents and loss of cohesion between sis-
ter chromatids were analyzed. (B) Cell
cultures of strains ySP1125 (WT),
ySP1145 (mad2D), ySP1016 (bub2D),
and ySP1072 (mad2D  bub2D), all ex-
pressing a Pds1 version tagged with 18
copies of the myc epitope (Pds1myc18;
Shirayama et al., 1998), were synchro-
nized in G1 with a factor (time 5 0)
and released in the presence of no-
codazole. To prevent reaccumulation
of Pds1 and Clb2, after 609 a factor was
added back to the cultures at a concen-
tration of 10 mg/ml. Cell samples were
collected at the indicated times for
Western blot analysis of Pds1myc18
and Clb2. Actin was used as loading
control. cyc, cycling culture.
strictly required for both the onset of anaphase and exit
from mitosis in the absence of Bub2  but not of  Mad2,
again consistently with the involvement of these two pro-
teins in different mitotic checkpoint pathways.
Discussion
Are Mitotic Checkpoint Proteins Involved in 
Controlling the Timing of Mitosis during a Normal
Cell Cycle?
The mitotic checkpoint is likely to play a crucial role also
during an unperturbed cell cycle, delaying the onset of
anaphase until all chromosomes are properly aligned on
the bipolar spindle and thereby preventing the occurrence
of aneuploidies. Mistakes made during mitosis may be re-
sponsible for the abnormal karyotype of many human tu-
mour cells and have an important role in oncogenesis.
Loss of function of the p53 tumour suppressor gene im-
pairs the mitotic checkpoint and the normal regulation of
centrosome duplication (Fukasawa et al., 1996). In addi-
tion, a number of human tumour cell lines have been re-
cently found to be defective in the activation of the mitotic
checkpoint in response to microtubule depolymerizing
drugs (Li and Benezra, 1996; Cahill et al., 1998). In addi-
tion, the chromosomal instability observed in two colorec-
tal cancers is associated to mutational inactivation of
BUB1 (Cahill et al., 1998). Finally, expression of dominant
negative mutant versions of either murine Bub1 or human
Mad1 accelerates exit from mitosis and causes accumula-
tion of multinucleate cells, respectively, even in the ab-Fraschini et al. Role of Bub2 in the Mitotic Checkpoint 987
sence of microtubule depolymerizing drugs, whereas mi-
croinjection of anti-Mad2 antibodies into mammalian cells
induces the onset of anaphase before chromosomes have
congressed to the metaphase plate (Gorbsky et al., 1998),
suggesting that these proteins play an important role in
regulating the normal timing of mitosis (Taylor and
McKeon, 1997; Jin et al., 1998). We tested directly whether
loss of function of MAD2, BUB2, or both, might acceler-
ate progression through mitosis of yeast cells. We found
that the kinetics of anaphase and exit from mitosis were
unaffected in mad2D, bub2D (Fig. 1) and mad2D bub2D
cells (data not shown) compared with wild-type. Since
mad mutants were shown to increase the frequency of
chromosome loss (Li and Murray, 1991), our data suggest
that either Bub and Mad proteins are not required for the
correct timing of mitosis during an unperturbed cell cycle,
or bipolar attachment of yeast chromosomes to spindle fi-
bers is so fast and efficient that does not enable to detect
subtle differences in the absence of surveillance mecha-
nisms. In agreement with the latter hypothesis is the find-
ing that in the absence of fission yeast Bub1 cells do not
prematurely enter mitosis despite showing massive chro-
mosome missegregation (Bernard et al., 1998).
Two Independent Pathways Involved in the
Mitotic Checkpoint
The mechanism by which Mad1, 2, 3 block cell cycle pro-
gression in response to spindle depolymerization or mono-
polar attachment has been recently uncovered. Mad2 has
been shown by several groups to bind and inactivate
Cdc20/APC, thus causing stabilization of Pds1 and cyclins
B with subsequent block of anaphase and mitotic exit
(Fang et al., 1998b; Hwang et al., 1998; Kallio et al., 1998;
Kim et al., 1998; Wassman and Benezra, 1998). This physi-
cal interaction might occur directly at the kinetochore;
consistently, the mammalian homologue of budding yeast
APC1, Tsg24, was constitutively localized at centromeres
(Jörgensen et al., 1998) and p55CDC, homologous to
Cdc20, was also found at kinetochores during mitosis (Kal-
lio et al., 1998). However, APC components, p55CDC and
HsMad1 have also been localized at centrosomes (Tu-
gendreich et al., 1995; Jin et al., 1998a; Kallio et al., 1998).
Our finding that BUB2 and MAD1, 2 belong to different
epistasis groups, as indicated by the accelerated degrada-
tion of Clb2, exit from mitosis and rereplication of mad1
bub2 and mad2 bub2 compared with that of the corre-
sponding single mutants, suggests that Bub2 might block
cell cycle progression in case of monopolar attachment of
chromosomes or spindle damage by a pathway distinct
from the one dependent on Mad1, 2. This conclusion is
further strengthened by the observation that cell cycle
progression of bub2D, but not mad2D, cells in nocodazole
depends on the unessential APC subunit Cdc26. Although
Cdc26 seems to be constitutively part of the APC, it is re-
quired for anaphase and ubiquitination of B-type cyclins
only at 378C; furthermore, it is induced after heat shock
(Zachariae et al., 1996). In S. pombe, overexpression of
the Cdc26 homologue Hcn1 suppresses a cut9 mutation
which causes defects in APC assembly (Yamada et al.,
1997). Thus, Cdc26/Hcn1 is a dispensable subunit that
might be only required to modulate APC activity under
stress conditions or when other APC subunits are defec-
tive (Townsley and Ruderman, 1998). The fact that cell cy-
cle progression of mad2, but not bub2, mutants tolerates
loss of Cdc26 function suggests that either Bub2 acts by fi-
nally inhibiting a special form of APC which requires
Cdc26, or that the function of a Cdc26-less APC is some-
what compromised already at 258C and the lack of Bub2 is
not sufficient to circumvent the defect.
The conclusion that Mad1, 2 and Bub2 both contribute
to the activation of the mitotic checkpoint via distinct
routes can only be drawn for what concerns mitotic exit,
which is a consequence of the inactivation of cyclin B–depen-
dent kinases. Conversely, loss of cohesion between sister
chromatids, which instead depends on Pds1 degradation, is
mostly driven by the inactivation of the Mad1, 2 pathway,
as the kinetics of sister chromatids separation of mad1D
bub2D and mad2D bub2D double mutants is very similar to
those displayed by mad1D or mad2D cells. Obviously,
bub2D cells are able to degrade Pds1 and attempt to un-
dergo anaphase to a certain extent in the absence of a
functional spindle, but this might be a consequence, rather
Figure 7. Cdc26 is required for cell cycle progression in nocoda-
zole of bubD but not mad2D cells. Cyclin cultures of strains
ySP601 (WT), ySP464 (mad2D), ySP862 (bub2D), ySP520
(cdc26D), ySP978 (bub2D cdc26D) and ySP1094 (mad2D cdc26D)
were arrested in G1 by a factor (time 5 0) and then released
from the block in the presence of nocodazole. Kinetics of replica-
tion analyzed by flow cytometry and of sister chromatids separa-
tion during the synchronous cell cycles are shown.The Journal of Cell Biology, Volume 145, 1999 988
than a primary effect, of the inactivation of mitotic CDKs.
Indeed, we found that degradation of Pds1 is very slow
and inefficient in bub2D cells in the presence of nocoda-
zole, suggesting that Bub2 plays only a minor role in con-
trolling the onset of anaphase. The loss of sister chroma-
tids cohesion we observe in bub2D cells treated with
nocodazole might just reflect a pathological situation
rather than shedding light on the actual role of Bub2. We
therefore propose that Bub2’s major, if not sole, role in the
activation of the checkpoint is to prevent, by inhibiting
B-type cyclins proteolysis, inactivation of mitotic CDKs
and, therefore, cytokinesis and entry into a new cell cycle.
The finding that the fission yeast homologue of Bub2,
Cdc16, in addition to having a role in the mitotic check-
point, is implicated in regulating septation and cytokinesis
during a normal cell cycle (Fankhauser et al., 1993; Furge
et al., 1998) supports this hypothesis. We currently do not
know the molecular mechanism by which the Bub2-depen-
dent pathway contributes to maintaining high levels of
these CDKs in nocodazole. In fact, Bub2 might inhibit di-
rectly the APC-dependent degradation of cyclins B, by in-
hibiting Hct1 or Cdc5 or even by interfering with the in-
tegrity of the APC subunit composition; alternatively, it
could prevent Sic1 accumulation or Cdc28 inhibitory phos-
phorylations on Thr18 and Tyr19, which have been previ-
ously  shown to play a role in the mitotic checkpoint
(Minshull et al., 1996; Wang and Burke, 1997). Whatever
the mechanism is, the absence of Bub2 in cells treated with
nocodazole might cause a drop in Clb1-4/Cdc28 kinase ac-
tivity, which would in turn lead to dephosphorylation and
unscheduled activation of Hct1; Hct1/APC, possibly spe-
cifically involving the Cdc26 subunit, would then promote
degradation of both mitotic cyclins and Pds1, despite
Cdc20 is kept inactive by the Mad1, 2 pathway. Several
lines of evidence strongly support this model: overexpres-
sion of Hct1 in nocodazole arrested cells is able to pro-
mote degradation of Pds1, albeit inefficiently (Visintin et al.,
1997), whereas deletion of BUB2 is sufficient to drive a
slow degradation of Pds1 and continuous cell cycle pro-
gression in cdc20 mutants (Shirayama et al., 1998; Tavor-
mina and Burke, 1998).
Relationships between the Function of Mitotic 
Checkpoint Proteins and Their Subcellular Localization
Many mitotic checkpoint proteins, like Mad1-3, Bub1, and
Bub3, have been localized at kinetochores not attached to
spindle fibers, such as in prophase and prometaphase of a
normal mitosis or in the presence of microtubule disrupt-
ing agents (Chen et al., 1996, 1997; Li and Benezra, 1996;
Taylor and McKeon, 1997; Taylor et al., 1998). Their local-
ization is fully consistent with previous lines of evidence
implicating the kinetochore in transmitting an inhibitory
signal to the cell cycle machinery in case of monopolar at-
tachment (Rieder et al., 1994, 1995). Other observations
suggested that the mitotic checkpoint also monitors the
lack of tension at kinetochores (Li and Nicklas, 1995;
Nicklas et al., 1995). Phosphorylation of the kinetochore-
associated 3F3/2 epitope correlates with the activation of
the mitotic checkpoint (Campbell and Gorbsky, 1995) and
is activated by tension (Nicklas et al., 1995). Conversely,
localization of Mad2 to kinetochores depends only on mi-
crotubule attachment but not on tension (Waters et al.,
1998), suggesting that different proteins might be involved
in sensing and transducing different signals. Localization
of Bub2 at SPBs does not correlate with the activation of
the mitotic checkpoint, but is fairly constitutive through-
out the cell cycle, raising the questions of how Bub2 func-
tion is regulated, whether it plays any role during a normal
cell cycle, and which signals it monitors. Whatever the sig-
nals are, we have shown that Bub2, as well as Mad2, is re-
quired to arrest cell cycle progression also after SPB sepa-
ration. One possibility is that signals coming from single
unattached kinetochores are integrated at SPBs, thus acti-
vating the Bub2 dependent checkpoint control. It is worth
noting that, unlike in other organisms (Chen et al., 1998),
human Mad1 is localized at kinetochores during inter-
phase but at centrosomes during mitosis (Jin et al., 1998a),
suggesting that microtubule organizing centers are likely
to play a central role in the mitotic checkpoint. Another
alternative is that the signal detected by Bub2 might be
different from that sensed by the other Mad and Bub pro-
teins; for instance, it has been proposed that Bub2 might
be involved in detecting alterations in the spindle struc-
ture, since it is not required to arrest the cell cycle in
response to impaired kinetochore function (Wang and
Burke, 1995). Unfortunately, this hypothesis cannot be
tested directly because spindle defects would necessarily
also compromise the kinetochore-microtubule attachment.
Finally, since we propose that Bub2 only plays a minor
role, if any, in regulating the degradation of Pds1 and sep-
aration of sister chromatids, we speculate that Bub2 might
be involved in the activation of the mitotic checkpoint
only later than the other Mad and Bub proteins, by pre-
venting cytokinesis and exit from mitosis until anaphase
has taken place. An intriguing hypothesis is that SPBs can
somehow monitor when anaphase has been completed,
and the inhibitory signal generated by Bub2 is rapidly ex-
tinguished when sister kinetochores have reached the
poles.
Which proteins does Bub2 interact with at SPBs in order
to prevent cytokinesis? Recent work in fission yeast has
started to elucidate the mechanism by which the Bub2 ho-
mologue Cdc16 might function. In fact, Cdc16 has been
found to physically interact with Byr4, which was previ-
ously implicated in the control of septation (Song et al.,
1996; Furge et al., 1998). The Cdc16/Byr4 complex dis-
plays GAP activity towards Spg1 (Furge et al., 1998), a
GTPase homologous to S. cerevisiae Tem1 (Shirayama et al.,
1994; Schmidt et al., 1997). Remarkably, Spg1 is constitu-
tively bound to SPBs and in the GTP-bound form seems to
recruit at SPBs the Cdc7 protein kinase, which is involved
in promoting cytokinesis (Fankhauser and Simanis, 1994;
Sohrmann et al., 1998). Mutations affecting budding yeast
TEM1 cause cells to arrest in telophase and have been re-
cently found to impair the APC-dependent ubiquitination
of mitotic cyclins (Shirayama et al., 1994; Jaspersen et al.,
1998), thus providing a link between SPBs, APC function,
and cytokinesis. The phenotype of tem1 mutants is very
similar to that of several mutants defective in late mitotic
events, like cdc15, dbf2, and cdc14. Their characterization
has uncovered a complex network of genetic interactions
which led to the hypothesis that all the corresponding
genes might be involved in the same process. In addition,Fraschini et al. Role of Bub2 in the Mitotic Checkpoint 989
Cdc14, which directly dephosphorylates both Sic1 and
Hct1, has been postulated to be the downstream effector
of the whole cascade (Visintin et al., 1998).
In conclusion, our current model of how the mitotic
checkpoint could work is depicted in Fig. 8. During
prophase, while chromosomes start to attach to spindle fi-
bers, Mad1, 2, 3, Bub1, and Bub3 present at unattached ki-
netochores prevent activation of Cdc20 and, therefore,
degradation of Pds1 and inactivation of mitotic CDKs. At
the same time Bub2, localized at SPBs, also prevents inhi-
bition of Clb1-4/Cdc28 kinases and cytokinesis by an inde-
pendent mechanism, which might involve inactivation of
late mitotic proteins, like Tem1, Cdc15, Dbf2, and Cdc14.
Exit from mitosis and cytokinesis are therefore blocked
until anaphase has taken place, a process which might
switch Bub2 function off. In the absence of Bub2 the ec-
topic activation of Hct1 triggered by Cdc14 would bring
about Pds1 degradation and sister chromatid separation
even if Cdc20 is kept inactive.
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